FR2308372A2 - Produits pharmaceutiques contenant un compose organosilicie en tant qu'agent actif - Google Patents

Produits pharmaceutiques contenant un compose organosilicie en tant qu'agent actif

Info

Publication number
FR2308372A2
FR2308372A2 FR7513152A FR7513152A FR2308372A2 FR 2308372 A2 FR2308372 A2 FR 2308372A2 FR 7513152 A FR7513152 A FR 7513152A FR 7513152 A FR7513152 A FR 7513152A FR 2308372 A2 FR2308372 A2 FR 2308372A2
Authority
FR
France
Prior art keywords
trimethylsilyl
para
treatment
troubles
medicaments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7513152A
Other languages
English (en)
French (fr)
Other versions
FR2308372B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cortial SA
Original Assignee
Cortial SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to AR260327A priority Critical patent/AR208203A1/es
Application filed by Cortial SA filed Critical Cortial SA
Priority to FR7513152A priority patent/FR2308372A2/fr
Priority to GB35280/75A priority patent/GB1508338A/en
Priority to DE19752538292 priority patent/DE2538292A1/de
Priority to NL7510317A priority patent/NL7510317A/xx
Priority to IL48052A priority patent/IL48052A0/xx
Priority to LU73351A priority patent/LU73351A1/xx
Priority to OA55605A priority patent/OA05105A/xx
Priority to ES440861A priority patent/ES440861A1/es
Priority to US05/611,847 priority patent/US4000265A/en
Priority to JP50109915A priority patent/JPS5238034A/ja
Priority to JP51023340A priority patent/JPS5215829A/ja
Publication of FR2308372A2 publication Critical patent/FR2308372A2/fr
Application granted granted Critical
Publication of FR2308372B2 publication Critical patent/FR2308372B2/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/695—Silicon compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0803—Compounds with Si-C or Si-Si linkages
    • C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR7513152A 1974-09-10 1975-04-21 Produits pharmaceutiques contenant un compose organosilicie en tant qu'agent actif Granted FR2308372A2 (fr)

Priority Applications (12)

Application Number Priority Date Filing Date Title
AR260327A AR208203A1 (es) 1974-09-10 1975-01-01 Proceso para la preparacion de acido p-trialquilsilil benzoico y derivados del mismo
FR7513152A FR2308372A2 (fr) 1975-04-21 1975-04-21 Produits pharmaceutiques contenant un compose organosilicie en tant qu'agent actif
GB35280/75A GB1508338A (en) 1974-09-10 1975-08-27 Pharmaceutical compositions
DE19752538292 DE2538292A1 (de) 1974-09-10 1975-08-28 Organosiliziumverbindungen enthaltende pharmazeutische zusammensetzungen
NL7510317A NL7510317A (nl) 1974-09-10 1975-09-02 Werkwijze voor het bereiden van een farmaceutisch preparaat waarin als werkzaam bestanddeel een organo-siliciumverbinding is opgenomen, en het volgens deze werkwijze verkregen preparaat.
IL48052A IL48052A0 (en) 1974-09-10 1975-09-04 Pharmaceutical compositions comprising as active agent an organosilicon compound
LU73351A LU73351A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1974-09-10 1975-09-09
OA55605A OA05105A (fr) 1974-09-10 1975-09-09 Procédé de fabrication de composés anti-athéromateux.
ES440861A ES440861A1 (es) 1974-09-10 1975-09-10 Procedimiento de fabricacion de derivados organicos del si- licio de caracter antiateromatoso.
US05/611,847 US4000265A (en) 1974-09-10 1975-09-10 Method for treating arteriosclerotic and cardiovascular disorders
JP50109915A JPS5238034A (en) 1974-09-10 1975-09-10 Medicine containing organosilion compound as active agent
JP51023340A JPS5215829A (en) 1975-04-21 1976-03-05 Medicine containing organosilicon compound as active agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7513152A FR2308372A2 (fr) 1975-04-21 1975-04-21 Produits pharmaceutiques contenant un compose organosilicie en tant qu'agent actif

Publications (2)

Publication Number Publication Date
FR2308372A2 true FR2308372A2 (fr) 1976-11-19
FR2308372B2 FR2308372B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1978-08-25

Family

ID=9154530

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7513152A Granted FR2308372A2 (fr) 1974-09-10 1975-04-21 Produits pharmaceutiques contenant un compose organosilicie en tant qu'agent actif

Country Status (2)

Country Link
JP (1) JPS5215829A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2308372A2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2454811A1 (fr) * 1978-11-09 1980-11-21 Rocher Pierre Appareil pour le traitement thermique, notamment l'aseptisation, des lentilles de contact
WO1995015760A1 (en) * 1993-12-10 1995-06-15 Merrell Pharmaceuticals Inc. Method of lowering serum cholesterol levels with 2,6-di-alkyl-4-silyl-phenols
US5677291A (en) * 1993-12-10 1997-10-14 Hoechst Marion Roussel, Inc. Method of lowering serum cholesterol levels with 2,6-di-alkyl-4-silyl-phenols
US6114572A (en) * 1996-11-20 2000-09-05 Hoechst Marion Roussel, Inc. Substituted phenols and thiophenols useful as antioxidant agents

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI679207B (zh) * 2018-05-07 2019-12-11 達興材料股份有限公司 含矽化合物、使用此含矽化合物的液晶組成物及液晶顯示裝置

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5945M (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1965-07-29 1968-04-08

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5945M (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1965-07-29 1968-04-08

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2454811A1 (fr) * 1978-11-09 1980-11-21 Rocher Pierre Appareil pour le traitement thermique, notamment l'aseptisation, des lentilles de contact
WO1995015760A1 (en) * 1993-12-10 1995-06-15 Merrell Pharmaceuticals Inc. Method of lowering serum cholesterol levels with 2,6-di-alkyl-4-silyl-phenols
US5677291A (en) * 1993-12-10 1997-10-14 Hoechst Marion Roussel, Inc. Method of lowering serum cholesterol levels with 2,6-di-alkyl-4-silyl-phenols
US5962435A (en) * 1993-12-10 1999-10-05 Hoechst Marion Roussel, Inc. Method of lowering serum cholesterol levels with 2,6-di-alkyl-4-silyl-phenols
US6114572A (en) * 1996-11-20 2000-09-05 Hoechst Marion Roussel, Inc. Substituted phenols and thiophenols useful as antioxidant agents

Also Published As

Publication number Publication date
JPS5215829A (en) 1977-02-05
FR2308372B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1978-08-25

Similar Documents

Publication Publication Date Title
MY110110A (en) Pharmaceuticals in the treatment of gastrointestinal disorders, cardiovascular disorders and cns disorders
IE862404L (en) Hydroxamic acid derivatives
GR3021789T3 (en) 17-Aryl and 17-heterocyclyl-14beta-5alpha-androstane, androstene and androstadiene derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing same
HUT50786A (en) Process for producing new condensed heterocyclic compounds and pharmaceutical compositions containing them as active components
UA29450C2 (uk) Похідні гідроксамової кислоти, спосіб їх одержання, спосіб впливу на хвороби та фармацевтична або ветеринарна композиція, що їх містить
IL76932A (en) Synergistic pharmaceutical analgesic compositions containing dihydrocodeine and ibuprofen
MX9603520A (es) Derivados del acido hidroxamico y acido carboxilico, procesos para su preparacion y su uso.
ES8105283A1 (es) Un procedimiento para la preparacion de nuevas 3-hidroxi-3- pirrolin-2, 5-dionas-4-sustituidas
DE3366932D1 (en) New derivatives of biliary acids, process for the production thereof and pharmaceutical compositions containing the same
JPS5251327A (en) 3-trihydroxygermylpropionic acid and its salts and process for prepari ng the same
EP0293751A3 (en) Taurohyodeoxycholic acid for the therapy of calculosis of the biliary tract and of biliary dyspepsia
HUT38255A (en) Process for preparing pharmaceutical compositions containing pyrimido-pyrimidines and o-acetyl-salicylic acid resp. pharmaceutically acceptable salts thereof
FR2308372A2 (fr) Produits pharmaceutiques contenant un compose organosilicie en tant qu'agent actif
JPS5543078A (en) Preparation of 1,3-dithiolan-2-ylidenemalonate derivative
DE3160595D1 (en) Polyprenyl carboxylic acid derivatives, process for the preparation of the same, and pharmaceutical compositions
FR2284331A1 (fr) Produits pharmaceutiques contenant un compose organo-silicie en tant qu'agent actif
ES8707734A1 (es) Procedimiento para la obtencion de cefalosporinas
GB1402691A (en) Composition of 4-biphenyl acetic acid
PT82202A (en) Process for the preparation of polyprenyl compounds
JPS5679622A (en) Antitumor pharmaceutical
OA07521A (fr) Nicotonamide 1-substitué, ses sels, procédé pour leur préparation et compositions pharmaceutiques en contenant.
WO1990003172A3 (en) Bile acids for treatment of viral infections
GR3035059T3 (en) Use of beta-naphthoquinone for accelerating the proliferation of endothelial cells and inhibiting no synthases.
ES8203086A1 (es) Un procedimiento para la produccion de n,n'-bis-(3-picolil) -4-metoxi-isoftalamida monohidratada
WO1987003590A1 (en) Medicament for the treatment of diseases of the liver